Supplementary Figure S1 : Caspase-induced iASPP cleavage in response to DNA damage reagents. A. Schematic representation of the iASPP protein and locations of residues recognized by anti-iASPP antibodies. B.
Supplementary Figure S2 : Time-dependent iASPP cleavage in vivo at its N-19 terminus A. Cell-free extracts from CEM cells were generated. Cyt c and dATP were added and the reactions performed at 37°C, for the indicated time periods, to trigger caspase activation. Cleavage of endogenous iASPP or in vitro translated C-terminally v5 tagged iASPP that was added to apoptotic cell-free extracts were detected with anti-iASPP antibody LX49.3 and anti-v5 tag antibody, respectively. PCNA or β-tubulin were used as loading controls to confirm that the same amount of cell-free extracts had been added into the reaction system. The arrowheads indicate iASPP and iASPP cleavage products of about 80kDa and 95kDa. B. Schematic representation of iASPP, truncated iASPP and the predicted iASPP caspase cleavage products. At the top of the diagram, FL-iASPP is schematically represented with its functional domains. Below this, the full length iASPP-v5, v5-iASPP and iASPP truncated products are shown as lines. The arrowheads indicate the potential iASPP cleavage sites responsible for the production of 95kDa (red) and 80kDa (green) iASPP fragments from full length iASPP. SH, Src homology domains; Pro, proline rich domain; Ank, ankyrin repeats. C. iASPP is cleaved at C-terminus. FL-iASPP-v5, tagged at the C-terminus (iASPP-v5) was translated in vitro. The same amounts of products were mixed with apoptotic CEM cell-free extract, triggered by adding cytochrome c and dATP. The reactions were performed at 37°C for 1 hour. z-VAD-FMK was added as indicated to inhibit apoptosis. The proteins were separated by 8% SDS-PAGE and blotted with anti-v5 antibody.
